Several publications have shown in PAH patients a disturbance in glucose metabolism associated with IR, demonstrated by higher levels of glucose, insulin, and lipids in those patients (14, 23, 25, 27–29). The gene discussed is INS; the disease is pulmonary arterial hypertension.